Browsing by Subject
Mostrando ítems 1-1 de 1
-
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
(Published by Oxford University Press, 2020-04)
Mostrando ítems 1-1 de 1